Iikura Y, Matsumoto T, Fujita K, Otsuka T, Sakamoto Y, Yun S K, Saito H, Obata T, Akasawa A, Capulong M C, Sakaguchi N, Oya Y, Tahara K, Tachimoto H, Kawahara H, Koya N
Department of Pediatrics, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan.
Int Arch Allergy Immunol. 1997 May-Jul;113(1-3):370-2. doi: 10.1159/000237606.
We studied the 1-type isoproterenol inhalation therapy for patients with severe asthmatic attacks who were admitted at the Department of Allergy of National Children's Hospital from 1981 to 1991. One hour after l-type isoproterenol inhalation therapy, statistically significant effects were noted with regard to the asthmatic status. Moreover, no side effect was found amoung the subjects. From these data, 1-type isoproterenol inhalation therapy is thought to be effective for severe asthmatic attacks.
我们对1981年至1991年期间在国立儿童医院过敏科住院的重度哮喘发作患者进行了1-异丙肾上腺素吸入疗法的研究。在1-异丙肾上腺素吸入疗法1小时后，哮喘状况出现了具有统计学意义的改善。此外，在研究对象中未发现副作用。基于这些数据，1-异丙肾上腺素吸入疗法被认为对重度哮喘发作有效。
